Novelogics is a privately-held, preclinical stage biotech company developing a novel monoclonal antibody immunotherapy drug for the treatment of cancer. The company is based in Vancouver, Canada. Our antibody drug interacts with target proteins known to be immune suppressive and which function to reduce the ability of the immune system to detect and destroy unwanted cancer cells. This drug target is found in multiple deadly cancer types including solid tumors, blood cancers and in other diseases, thereby implying that the potential market for our drug is large. Novelogics’ innovative therapeutic approach restores immune responses against cancer cells and is expected to treat cancer patients in a safer fashion while maintaining their quality of life.
Company Details
- Employees
- 1
- Founded
- 2013
- Address
- Vancouver, Bc V3c 0a3, Ca
- in****@****ics.com
- Industry
- Biotechnology
- Website
- novelogics.com
- HQ
- Vancouver, BC
Novelogics Biotechnology Inc. Questions
Novelogics Biotechnology Inc.'s website is novelogics.com
Novelogics Biotechnology Inc.'s LinkedIn profile is https://ca.linkedin.com/company/novelogics
Novelogics Biotechnology Inc. has
1 employees.
View email and phone details for 1
employees at Novelogics Biotechnology Inc..
Novelogics Biotechnology Inc.'s industry is
Biotechnology
Novelogics Biotechnology Inc.'s top competitors are
Virogin Biotech,
Xenon Pharmaceuticals Inc.,
Gene Bio Medical (Gene Biotechnology Enterprises Ltd.),
Lepzi Biotechnology Ltd.,
Oceanix Biotechnology Corporation,
Apricell Biotechnology Inc.,
Synth-Med Biotechnology Inc.,
Qu Biologics Inc.,
Aspect Biosystems,
Zymeworks Inc..
Novelogics Biotechnology Inc.'s support email address is info@novelogics.com
Novelogics Biotechnology Inc.'s categories are Biotechnology
Novelogics Biotechnology Inc.'s founding year is 2013
